Kent Lake PR’s Neuronetics STIM Stock Holding History

Kent Lake PR’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,077,848	Closed	-$1.58M	–	52
2024 Q3	$1.58M	Buy	+2,077,848	New	+$2.73M	0.63%	41

Other funds holding STIM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Kent Lake PR's STIM Position: Q4 2024 in Review

Kent Lake PR sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 2,077,848 shares — an estimated $1.58M sold.

Kent Lake PR first reported a position in STIM in Q3 2024 and held it in 1 quarter. The position peaked at $1.58M in Q3 2024. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

Kent Lake PR reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
Kent Lake PR sold 2,077,848 Neuronetics shares in Q4 2024, an estimated $1.58M.
Kent Lake PR first reported a position in Neuronetics in Q3 2024 and held it in 1 quarter.
Kent Lake PR's Neuronetics position peaked at $1.58M in Q3 2024.
45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on Kent Lake PR's 13F filing for Q4 2024, filed 14 Feb 2025.